11 – 20 of 2269
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
- Contribution to journal › Article
-
Mark
A non-genotoxic stem cell therapy boosts lymphopoiesis and averts age-related blood diseases in mice
- Contribution to journal › Article
-
Mark
Medium-dose irradiation impairs long-term hematopoietic stem cell functionality and hematopoietic resilience to cytotoxic stress
- Contribution to journal › Article
-
Mark
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
- Contribution to journal › Article
-
Mark
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
- Contribution to journal › Letter
-
Mark
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab : Results From the Phase IV HemiNorth 2 Study
(2025) In Haemophilia
- Contribution to journal › Article
-
Mark
Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder
(2025) In Blood Advances
- Contribution to journal › Article
-
Mark
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
(2025) In Leukemia
- Contribution to journal › Article
-
Mark
Insights from Single-cell Omics - Cellular Heterogeneity as a Foundation of Clinical Outcome in Chronic Myeloid Leukemia
(2025) In Blood
- Contribution to journal › Scientific review
-
Mark
Intracranial hemorrhage before start of prophylaxis in children with hemophilia : incidence, timing, and potential for prevention
- Contribution to journal › Article
